US0028241000
US0028241000
Abbott Laboratories
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 173.48B EUR | 157.93B EUR | 178.83B EUR | 217.58B EUR |
Enterprise Value | 198.19B EUR | 157.93B EUR | 206.08B EUR | 222.92B EUR |
Valuation Multiples | ||||
Trailing P/E | 32.13x | 35.12x | 28.49x | 33.35x |
Forward P/E | 16.42x | -- | -- | -- |
Price to Sales | 3.72x | 4.65x | 3.96x | 4.91x |
Price to Book | 3.37x | -- | 3.44x | 4.17x |
EV/Revenue | 4.25x | 4.65x | 4.57x | 5.03x |
EV/EBITDA | 16.97x | 18.06x | 17.49x | 18.54x |
Price to FCF (P/FCF) | 24.06x | 27.07x | 24.24x | 29.42x |
EV/FCF | 27.49x | 27.07x | 27.93x | 30.14x |
FCF Yield | 4.16% | 3.69% | 4.13% | 3.4% |